Who Paid My Doc
Taperloc
Device Hips
PDI 00889024516595
General payments
$1,569,832
Research payments
$76,880
Through program year 2025, $1,569,832 in general payments and $76,880 in research payments were reported against Taperloc (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $12,559 | 34 |
| 2025 | Research | $9,514 | 4 |
| 2024 | General | $83,288 | 49 |
| 2024 | Research | $61,301 | 7 |
| 2023 | General | $252,182 | 172 |
| 2023 | Research | $2,770 | 3 |
| 2022 | General | $1,221,803 | 51 |
| 2022 | Research | $3,295 | 3 |
Breakdown
The top 5 of 27 recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
306 general · 17 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.